TRAF1 and hepatocellular carcinoma: In this manner, a positive feedback loop involving DNMT1, miR‐378a‐3p, TRAF1 and NF‐κB plays a critical role in HCC cells, suggesting its potential as a viable therapeutic target for HCC [44].